RU2006101150A - Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз - Google Patents
Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз Download PDFInfo
- Publication number
- RU2006101150A RU2006101150A RU2006101150/14A RU2006101150A RU2006101150A RU 2006101150 A RU2006101150 A RU 2006101150A RU 2006101150/14 A RU2006101150/14 A RU 2006101150/14A RU 2006101150 A RU2006101150 A RU 2006101150A RU 2006101150 A RU2006101150 A RU 2006101150A
- Authority
- RU
- Russia
- Prior art keywords
- eyes
- nesteroid
- compositions
- treatment
- pathological angiogenesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47822703P | 2003-06-13 | 2003-06-13 | |
| US47825203P | 2003-06-13 | 2003-06-13 | |
| US60/478,252 | 2003-06-13 | ||
| US60/478,227 | 2003-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006101150A true RU2006101150A (ru) | 2006-06-10 |
Family
ID=33544369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006101150/14A RU2006101150A (ru) | 2003-06-13 | 2004-06-14 | Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070043006A1 (enExample) |
| EP (1) | EP1633339A4 (enExample) |
| JP (1) | JP2007500250A (enExample) |
| KR (1) | KR20060019579A (enExample) |
| AU (1) | AU2004249167A1 (enExample) |
| BR (1) | BRPI0411427A (enExample) |
| CA (1) | CA2527121A1 (enExample) |
| MX (1) | MXPA05012696A (enExample) |
| RU (1) | RU2006101150A (enExample) |
| WO (1) | WO2004112772A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1635842A4 (en) * | 2003-06-20 | 2007-04-04 | Alcon Inc | TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS |
| TW200812575A (en) * | 2006-04-28 | 2008-03-16 | Alcon Inc | Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye |
| ES2667945T3 (es) * | 2007-10-08 | 2018-05-16 | Aurinia Pharmaceuticals Inc. | Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR |
| WO2010144194A1 (en) * | 2009-06-09 | 2010-12-16 | Lux Biosciences, Inc. | Topical drug delivery systems for ophthalmic use |
| US9630909B2 (en) | 2013-06-27 | 2017-04-25 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975537A (en) * | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
| US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| CA1331559C (en) * | 1986-04-21 | 1994-08-23 | Jon Joseph Kabara | Antimicrobial preservative compositions and methods |
| US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
| US4910225A (en) * | 1988-01-27 | 1990-03-20 | Senju Pharmaceutical Co., Ltd. | Locally administrable therapeutic composition for inflammatory disease |
| US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
| EP0533703B1 (en) * | 1990-06-11 | 2000-03-15 | Alcon Laboratories, Inc. | Use of steroids for the inhibition of angiogenesis |
| US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5770592A (en) * | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| WO1997041867A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Use of steroid compounds to prevent non-cancerous tissue growth |
| US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
| PT1221918E (pt) * | 1999-10-21 | 2005-06-30 | Alcon Inc | Administracao de drogas sub-tenon |
| KR100732262B1 (ko) * | 1999-10-21 | 2007-06-25 | 알콘, 인코퍼레이티드 | 약물 전달 장치 |
| US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| AR030346A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico |
| US6646003B2 (en) * | 2001-04-02 | 2003-11-11 | Alcon, Inc. | Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac |
-
2004
- 2004-06-14 CA CA002527121A patent/CA2527121A1/en not_active Abandoned
- 2004-06-14 MX MXPA05012696A patent/MXPA05012696A/es not_active Application Discontinuation
- 2004-06-14 AU AU2004249167A patent/AU2004249167A1/en not_active Abandoned
- 2004-06-14 WO PCT/US2004/018792 patent/WO2004112772A1/en not_active Ceased
- 2004-06-14 KR KR1020057023543A patent/KR20060019579A/ko not_active Withdrawn
- 2004-06-14 EP EP04755138A patent/EP1633339A4/en not_active Withdrawn
- 2004-06-14 US US10/557,133 patent/US20070043006A1/en not_active Abandoned
- 2004-06-14 US US10/867,289 patent/US20040259765A1/en not_active Abandoned
- 2004-06-14 RU RU2006101150/14A patent/RU2006101150A/ru unknown
- 2004-06-14 BR BRPI0411427-2A patent/BRPI0411427A/pt not_active IP Right Cessation
- 2004-06-14 JP JP2006533771A patent/JP2007500250A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060019579A (ko) | 2006-03-03 |
| US20040259765A1 (en) | 2004-12-23 |
| AU2004249167A1 (en) | 2004-12-29 |
| US20070043006A1 (en) | 2007-02-22 |
| EP1633339A1 (en) | 2006-03-15 |
| WO2004112772A1 (en) | 2004-12-29 |
| BRPI0411427A (pt) | 2006-07-25 |
| CA2527121A1 (en) | 2004-12-29 |
| EP1633339A4 (en) | 2009-06-03 |
| JP2007500250A (ja) | 2007-01-11 |
| MXPA05012696A (es) | 2006-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| RU2498988C2 (ru) | Ингибиторы активности протеинтирозинкиназы | |
| DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| EA200801492A1 (ru) | Фармацевтическое применение замещенных амидов | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| EA200900940A1 (ru) | Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное | |
| RU2010138638A (ru) | Новые применения 4-фенилбутирата натрия (4фб) и его фармацевтически приемлемых солей | |
| BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
| EP1251126A3 (en) | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation | |
| DK2017276T3 (da) | Phenylcarboxamid-forbindelser til behandling af smerte | |
| WO2002009702A3 (en) | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure | |
| EE05315B1 (et) | Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette nhtud imetajal esineva seksuaalse funktsioonihire ravimiseks v?i m?jutamiseks | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| BR0313718A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto | |
| BR9910899A (pt) | Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida | |
| RU2004103746A (ru) | Фармацевтическая композиция для лечения интерстициального цистита | |
| RU2006101150A (ru) | Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| CA2534634A1 (en) | Azolidinecarbonitriles and their use as dpp-iv inhibitors | |
| RU2007126638A (ru) | Профилактическое или терапевтическое средство для лечения расстройства сна | |
| RU2004129767A (ru) | Хинолиновые производные | |
| DE60121695D1 (de) | Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen | |
| RU2009138028A (ru) | Новое профилактическое и/или лекарственное средство против невропатической боли | |
| DE60329014D1 (de) | Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen |